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ABSTRACT -___ 
The interactions of a proposed, selective delta receptor antagonist (ICI 
174,864) and selective agonists at mu and delta receptors, [D-Ala2, NMePhe4, 
Gly-all-enkephalin (DAGO) and [D-Pen2, D-Pen5]-enkephalin (DPDPE), respec- 
tively, have been studied using the electrically-stimulated mouse isolated 
vas deferens (MVD) and the guinea-pig isolated ileum (GPI). Incubation of 
increasing concentrations of ICI 174,864 (10,30,100 and 300 nM) produced a 
dose-related and parallel rightward displacement of the DPDPE dose-response 
curve in the MVD. In contrast, ICI 174,864 (300-3000 nM) failed to affect 
the DAGO dose-response curve in the same tissue. Analysis of the DPDPE-ICI 
174,864 interaction in the MVD using the pA2 method revealed a Schild plot 
slope of -0.68 suggesting the involvement of more than one population of 
receptors. ICI 174,864 (300 nM) failed to antagonize DPDPE in the GPI at 
doses up to 30 uM. These results suggest that (a) ICI 174,864 acts as a 
selective delta antagonist in the MVD; (b) DPDPE interacts with mu receptors 
in the MVD but only at very high concentrations, and (c) delta receptors 
appear not to be of functional importance in the GPI. 
INTRODUCTION 
The existence of multiple opioid receptor subtypes has been postulated 
based in part on extensive work in vitro using the electrically stimulated 
guinea-pig isolated ileum (GPI) and the mouse vas deferens (MVD)(l). The 
importance of these in vitro bioassays may be viewed in part, as a basis for 
predicting the actions of opioids in vivo. Agonists which demonstrate a high 
degree of preference for the specific receptor subtypes in these tissues have 
been developed. These selective agonists include [D-Ala2, NMePhe4, Gly-olj- 
enkephalin (DAGO) for the mu receptor (2) and cyclic [D-Pen2, D-Pen5]- 
enkephalin (DPDPE) for the delta receptor (3). Recently, ICI 174,864 [Allyl2- 
Tyr-Aib-Aib-Phe-Leu-OH], has been reported to be a compound with selective 
antagonist properties at the delta receptor (4). The present work 
investigated the selectivity profile of ICI 174,864 in the MVD using the 
selective delta and mu agonists, DPDPE and DAGO, respectively. Further, the 
ability of ICI 174,864 to antagonize DPDPE in the GPI was studied in an 




Strips of longitudinal muscle-myenteric plexus were taken from Hartley 
guinea-pigs of either sex (300-400 g) and suspended in Krebs-bicarbonate buffer 
at 37" C in an organ bath. Similarly, vasa deferentia from male, ICR mice 
(25-30 g) were removed and suspended in magnesium-free Krebs-bicarbonate 
buffer. The tissues were transmurally stimulated with supramaximal pulses 
(0.1 Hz, 20 V, 0.4 msec, GPI; 0.1 Hz, 20 V, 2 msec, MVD) as previously 
described (3). Agonists were placed in the bath and the twitch height was 
measured after 3 min. The antagonist was added to the bath 2 min prior to 
the agonist, with 8 min being allowed between successive doses of agonist. 
RESULTS 
ICI 174,864 displaced the DPDPE dose-response curve to the right in a 
dose-related and parallel fashion in the MVD (fig. 1). In contrast, ICI 
174,864 failed to displace the DAGO dose-response curve to the right in the 
same tissue (fig. 2). In the GPI, DPDPE acted as a full agonist, though at 
doses 1000 fold higher than those necessary for activity in the MVD. The IC50 
for DPDPE in the CPI was calculated to be 14.5 (8.3 - 25.4) PM. ICI 174,864 
failed to antagonize DPDPE in the GPI at a dose (300 nM) that effectively 
blocked the effects of this agonist in the MVD (fig. 3). 
Analysis of the ICI 174,864-DPDPE interaction in the MVD using the pA2 
approach revealed a linear 
a pA2 of 8.23 (8.09-8.37). 
Schild plot (r = 0.98) with a slope of l0.687.and 
DISCUSSION 
The present study has attempted to determine the selectivity profile of 
ICI 174,864 in vitro using the most selective agonists at mu (DAGO) and delta 
(DPDPE) receptors currently available. ICI 174,864 inhibited the effect ot 
DPDPE, but not that of DAGO, in the MVD, indicating a selective interaction 
of the antagonist with delta receptors. However, when the ICI 174,864-DPDPE 
PAN was determined, the slope of the Schild plot was found to differ from 
the theoretically predicted unity. This deviation from theory may be 
explained on the basis of a non-preferential interaction of DPDPE with mu 
receptors, known to be present in the MVD. The observation of a Schild slope 
differing from unity has been previously reported (4) using ICI 174,864 and 
[D-Thr2, Leu5, Thr6]-enkephalin (DTLET). These investigators showed that the 
Schild slope reverted to unity when the tissues studied were taken from 
C57BL/6 mice, a species previously found to be lacking in mu receptors (5). 
In contrast to the activity of ICI 174,864 in atagonizing DPDPE in the 
MVD, this compound was ineffective against the delta agonist in the GPI. 
This finding suggests that DPDPE is interacting with mu, rather than delta, 
receptors in this tissue. It should be noted that a high dose of DPDPE is 
required for activity (30 HIM> in the GPI and even a high dose of ICI 174,864 
(300 nM) was not effective, adding to the belief of mu receptor involvement. 
The presence of functional delta receptors in the GPI is controversial. 
Using the non-equilibrium opioid antagonist, beta-Lhlornaltrexamine, some 
investigators have suggested that delta receptors are present in the ileum 
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Figure 1. Interaction of increasing concentrations of ICI 174,864 and DPDPE 
in the mouse vas deferens. 
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Figure 2 (left). Interaction of increasing concentrations of ICI 174,864 and 
DAGO in the mouse vas deferens. 
Figure 3 (right). Interaction of DPDPE with ICI 174,864 (300 KIM) in the GPI. 
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GPI, the present results suggest that delta receptors are of little functiona 
importance in this tissue. 
The present work supports the concept of ICI 174,864 as a selective 
delta antagonist in vitro. However, the profile of this compound in vivo as 
reported in the current Proceedings (7,8) suggests only a partially-selective 
antagonist with a narrow window of activity. Furthermore, agonist effects 
of ICI 174,864 were also observed, suggesting that the profile of agonists 
and antagonists in bioassays must be viewed with caution. The usefulness of 
ICI 174,864 in other assays in vitro remains to be determined. 
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